PRO224 gene disruptions, and methods related thereto

Multicellular living organisms and unmodified parts thereof and – Method of using a transgenic nonhuman animal in an in vivo...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C800S021000

Reexamination Certificate

active

08067664

ABSTRACT:
The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO224, PRO9783, PRO1108, PRO34000, PRO240, PRO943, hu A33, PRO230, PRO178, PRO1199, PRO4333, PRO1336, PRO19598, PRO1083, hu TRPM2 or PRO1801 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

REFERENCES:
patent: 6436707 (2002-08-01), Zambrowicz et al.
patent: 2002/0137900 (2002-09-01), Ferrara et al.
patent: 2004/0067553 (2004-04-01), Masanori
patent: WO 99/14328 (1999-03-01), None
patent: WO 01/87932 (2001-11-01), None
patent: WO 02/053593 (2002-07-01), None
Upton et al., Lack of 5-HT1B receptor and of serotonin transporter have different effects on the segregation of retinal axons in the lateral geniculate nucleus compared to the superior colliculus, Neuroscience, 111(3):597-610, 2002.
Ristevski, Making better transgenic models: conditional, temporal, and spatial approaches. Mol Biotechnol. 29(2): 153-63, 2005.
Montoliu, Gene transfer strategies in animal transgenesis. Cloning Stem Cells. 4(1): 39-46, 2002.
Clark et al., The mammary gland as a bioreactor: expression, processing, and production of recombinant proteins, J Mammary Gland Biol Neoplasia. 3(3):337-50, 1998.
Williams, Death of Dolly marks cloning milestone, Curr Biol. 13(6):R209-10, 2003.
Denning et al, New frontiers in gene targeting and cloning: success, application and challenges in domestic animals and human embryonic stem cells. 2003, Reproduction, 126: 1-11, 2003.
Matthaei, Genetically manipulated mice: a powerful tool with unsuspected caveats. J Physiol. 582(Pt 2):481-8, 2007.
Skolnick et al., From genes to protein structure and function: novel applications of computational approaches in the genomic era, Trends in Biotechnol. 18(1):34-39, 2000.
Abu-Elheiga, L. et al., “Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2”Science291:2613-16 (Mar. 30, 2001).
Abud, H. E, et al., “The murine A33 antigen is expressed at two distinct sites during development, the ICM of the blastocyst and the intestinal epithelium”Mechanisms of Development98:111-14 (2000).
Beltowski, J., “Adiponectin and resistin—new hormones of white adipose tissue.”Med Sci Monit. 9(2) :RA55-61 (Feb. 2003).
Bromme, N. C., et al., “Cloning, Characterization, and Expression of the Human TIN-ag-RP Gene Encoding a Novel Putative Extracellular Matrix Protein”Biochemical and Biophysical Research Communications271:474-80 (2000).
Chang, B., et al., “Identification of a missense mutation in the αA-crystallin gene of the lop18 mouse”Molecular Vision5:21-5 (1999).
Daly, N.L., et al., “Three-dimensional structure of a cysteine-rich repeat from the low-density lipoprotein receptor”Proc. Natl. Acad. Sci. 92:6334-38 (Jul. 1995).
DeLorey, T.M. et al., “Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavorial characteristics of Angelman syndrome.”Neuroscience18(20) :8505-14 (Oct. 15, 1998).
Dumoutier et al., “Cloning and Characterization of IL-22 Binding Protein, a Natural Antagonist of IL-10-Related T Cell-Derived Inducible Factor/IL-22”Journal of Immunology166:7090-7095 (2001).
Eby, M. T., et al., “TAJ, a Novel Member of the Tumor Necrosis Factor Receptor Family, Activates the c-Jun N-Terminal Kinase Pathway and Mediates Caspase-independent Cell Death”The Journal of Biological Chemistry275(20) :15336-42 (May 19, 2000).
Esther, R.C. et al., “Mice Lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility.”Laboratory Investigation74(5) :953-65 (May 1996).
Giese, A., et al., “Molecular characterization of the equine testis-specific protein 1 (TPX1) and acidic epididymal glycoprotein 2 (AEG2) genes encoding members of the cysteine-rich secretory protein (CRISP) family”Gene299:101-109 (2002).
Giros, B., et al., “Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter”Nature379:606-12 (Feb. 15, 1996).
Hara, Y., et al., “LTRPC2Ca2+-Permeable Channel Activated by Changes in Redox Status Confers Susceptibility to Cell Death”Molecular Cell9:163-73 (Jan. 2002).
Hawes, N. L., et al., “Mouse fundus photography and angiography: A catalogue of normal and mutant phenotypes”Molecular Vision5:22 (Aug. 1999).
Holcomb et al., “FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family”EMBO Journal19(15) :4046-4055 (2000).
Holmes, G., et al., “Expression of slit-2 and slit-3 during chick development.”Dev Dyn. 222(2) :301-7 (Oct. 2001).
Homanics, G. E., et al., “Mice devoid of γ-aminobutyrate type A receptor β3 subunit have epilepsy, cleft palate, and hypersensitive behavior”Proc. Natl. Acad. Sci. USA94:4143-8 (Apr. 1997).
Hu et al., “Characterization of TNFRSF19, a novel member of the tumor necrosis factor receptor superfamily”Genomics62(1) :103-107 (Nov. 15, 1999).
Kim, I., et al., “A novel fibroblast growth factor receptor-5 preferentially expressed in the pancreas(1).”Biochim Biophys Acta1518(1-2) :152-6 (Mar. 19, 2001).
Kobayashi, M., et al., “Isolation of an androgen-inducible novel lipocalin gene, Argl, from androgen-dependent mouse mammary Shionogi carcinoma cells.”Steroid Biochem Mol Biol77(2-3) :109-15 (May 2001).
Kojima, T., et al., “TROY, a Newly Identified Member of the Tumor Necrosis Factor Receptor Superfamily, Exhibits a Homology with Edar and Is Expressed in Embryonic Skin and Hair Follicles”The Journal of Biological Chemistry275(27) :20742-47 (Jul. 7, 2000).
Kotenko et al., “Identification, Cloning, and Characterization of a Novel Soluble Receptor That Binds IL-22 and Neutralizes Its Activity1,2”J. Immunol. 166:7096-7103 (2001).
Langenbach, R. et al., “Prostaglandin Synthase 1 Gene Disruption in Mice Reduced Arachidonic Acid-Induced Inflammation and Indomethancin-Induced Gastric Ulceration”Cell83:483-92 (Nov. 3, 1995).
Leung, D.W., “The structure and functions of human lysophosphatidic acid acyltransferases.”Frontiers in Bioscience6:D944-53 (Aug. 2001).
Li, L., et al., “Identification of a Human Follicular Dendritic Cell Molecule That Stimulates Germinal Center B Cell Growth”Journal of Experimental Medicine191(6) :1077-83 (Mar. 20, 2000).
Little, M. H., et al., “Dual trafficking of Slit3 to mitochondria and cell surface demonstrates novel localization for Slit protein”Am J Physiol Cell Physiol281:C486-95 (2001).
Liu, M., et al., “GPR56, a Novel Secretin—like Human G-Protein-Coupled Receptor Gene”Genomics55:296-305 (1999).
Louie and Edwards, “Hypertrophic Cardiomyopathy”Prog. Cardiovasc. Dis. 36:275-308 (1994).
Milne, T. J., et al., “Isolation and Characterization of a Cone Snail Protease with Homology to CRISP Proteins of the Pathogenesis-related Protein Superfamily”Journal of Biological Chemistry278(33) :31105-10 (Aug. 15, 2003).
Mukai, K., et al., “An Inverse Correlation between Expression of a Preprocathepsin B-related Protein with Cysteine-rich Sequences and Steroid 11β-Hydroxylase in Adrenocortical Cells”The Journal of Biological Chemistry278(19) :17084-92 (May 9, 2003).
Perraud, A., et al., “ADP-ribo

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

PRO224 gene disruptions, and methods related thereto does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with PRO224 gene disruptions, and methods related thereto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PRO224 gene disruptions, and methods related thereto will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4303578

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.